JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus

Clinical trial NCT05967520 · UNKNOWN

Trial details

NCT number: NCT05967520
Sponsor: Jemincare
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic

Start date: 2023-09-21
Primary completion: 2025-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.